Fed in No Rush: Powell Stands Firm as Trump Pushes for Rate Cuts

Key Points:
– Fed Chair Jerome Powell signals patience on interest rates amid economic and geopolitical uncertainty.
– Rising political pressure, including sharp criticism from President Trump, has not swayed the Fed’s cautious approach.
– Internal divisions within the Fed highlight uncertainty over the timing and necessity of potential rate cuts.

Federal Reserve Chair Jerome Powell has reaffirmed the central bank’s cautious stance on interest rate policy, signaling that the Fed is in no rush to cut rates as it awaits greater clarity on the economic impact of rising tariffs and geopolitical uncertainty.

In testimony before lawmakers, Powell said the Federal Reserve is “well-positioned to wait” before adjusting monetary policy, citing the need for more data on how recent trade actions and inflation trends will evolve. His remarks come at a time of heightened pressure from the White House, with President Trump calling for sharp and immediate rate cuts, and some Fed officials themselves suggesting a more dovish pivot.

“Increases in tariffs are likely to push up prices and weigh on economic activity,” Powell told members of Congress. He emphasized the uncertainty surrounding how lasting these effects might be. “The inflationary impact could be transitory, but it could also prove more persistent. We simply don’t know yet.”

The Fed has held rates steady for multiple consecutive meetings, keeping its benchmark range between 4.25% and 4.5%, and has maintained a data-dependent approach as economic conditions shift. Powell reiterated that any future move—whether a rate cut or continued pause—will depend on evolving inflation data, labor market health, and broader global developments.

The conversation around monetary policy has grown increasingly politicized. President Trump has sharply criticized Powell and the Fed’s decision-making, calling for rates to be slashed significantly. In public statements and on social media, Trump has demanded rates between 1% and 2%, going so far as to insult Powell personally and muse about removing him from his post.

Despite these attacks, Powell stood firm. “We are focused on one thing: delivering a good economy for the benefit of the American people,” he said. “Anything else is a distraction.”

While Powell maintained a neutral tone, some members of the Fed’s policymaking committee have expressed more urgency. Governor Michelle Bowman recently argued for potential rate cuts in the near term, citing weaker consumer spending and softening labor trends. Others, including Cleveland Fed President Beth Hammack, have countered that the economy remains too strong to justify immediate easing.

The division is also evident in the Fed’s internal projections. A recent summary of economic projections revealed a split among officials: some anticipate two rate cuts this year, while others favor keeping rates unchanged for longer, especially amid risks of renewed inflation due to tariffs and potential oil price shocks.

International developments, including tensions in the Middle East and volatile energy markets, add another layer of complexity. Some analysts warn that a sustained rise in oil prices—driven by potential disruptions in the Strait of Hormuz—could reignite inflation pressures and delay any rate relief.

Despite the political noise and market speculation, Powell has made clear that the Fed’s course will be guided by economic fundamentals. With inflation moderating but not vanquished, and growth showing signs of deceleration, the central bank faces a delicate balancing act in the months ahead.

Release – MAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory Board

Research News and Market Data on MAIA

June 24, 2025 8:15am EDT Download as PDF

Planning for Phase 2 clinical trial in hepatocellular carcinoma (HCC) underway

CHICAGO–(BUSINESS WIRE)– MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced the appointment of two prominent oncologists to its Scientific Advisory Board (SAB), Claudia Fulgenzi, MD, and David J. Pinato, MD, MRCP (UK), PhD. Both are specialists in hepatocellular carcinoma (HCC), a tumor type to be studied in future clinical trials of MAIA’s lead candidate ateganosine (THIO) sequenced with a checkpoint inhibitor.

As SAB members they will advise MAIA on designs and protocols for its company sponsored trial (CST) in HCC and may participate in future investigator sponsored trials (IST).

“Drs. Pinato and Fulgenzi are scientific experts on inflammation as a pathogenic and prognostic mechanism in primary liver cancers. Together, their research has focused on improving the treatment of HCC, particularly with the use of anti-cancer immunotherapy,” said MAIA Chairman and CEO Vlad Vitoc, M.D. “They will bring a wealth of knowledge to our SAB, with specialized expertise that will inform our plans and preparations for our upcoming clinical program in HCC.

“By the end of this year, we expect to have all required approvals to begin enrolling patients in a HCC trial,” Dr. Vitoc added.

MAIA was granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for ateganosine as a treatment for HCC in 2022. ODDs can provide up to seven years of market exclusivity.

Dr. David Pinato is a clinician scientist in the Department of Surgery and Cancer at Imperial College London and a consultant oncologist at Imperial College Healthcare NHS Trust. As Director of Developmental Cancer Therapeutics at Imperial College, he leads a translational research program focused on the early clinical implementation of novel experimental anticancer therapies with particular emphasis on anti-cancer immunotherapy.

Dr. Pinato’s research efforts in liver cancer have been recognized by the American Society of Clinical Oncology (ASCO) and the Society for Immunotherapy of Cancer (SITC). He has received awards by the British Society of Pharmacology and the Royal Society of Medicine, and fellowships by the European School of Oncology and Fulbright Program.

Dr. Pinato completed his core medical training across some of the busiest acute hospitals in London and was elected to the Royal College of Physicians (MRCP). His research has been published in leading journals in the field including the Journal of Clinical Oncology, Annals of Oncology, Hepatology and many others. Dr. Pinato lectures internationally in the field of molecular oncology with a specific interest in HCC and acts as a reviewer for several peer-reviewed journals including The Lancet, Cancer Discovery, Hepatology and Journal of Hepatology.

Dr. Claudia Fulgenzi is a specialist in medical oncology at Imperial College London, with dedicated professional interest in the field of immune-oncology and gastro-intestinal cancers, particularly hepatic-biliary malignancies. Dr. Fulgenzi graduated in medicine from the University of Rome Tor Vergata and subsequently specialized in medical oncology at the University Campus Bio Medico of Rome, Italy. Her contributions to the field have been recognized with prestigious awards including the ASCO Merit Award, the Young Investigator award by the International Liver Cancer Association (ILCA) and the American Society of Clinical Oncology.

Dr. Fulgenzi is actively engaged in clinical practice in London, serving as an honorary consultant in oncology at Chelsea and Westminster Hospital and as a specialty doctor in the early phase clinical trial unit at Hammersmith Hospital. In these capacities, she conducts clinical and translational research, contributes to clinical trial design, and provides expert medical guidance to cancer patients.

Hepatocellular carcinoma is the most frequently occurring primary liver tumor representing approximately 90% of all liver cancers. HCC currently ranks 5th by incidence and 3rd by mortality on a global scale.

About Ateganosine

Ateganosine (THIO, 6-thio-dG or 6-thio-2’-deoxyguanosine) is a first-in-class investigational telomere-targeting agent currently in clinical development to evaluate its activity in non-small cell lung cancer (NSCLC). Telomeres, along with the enzyme telomerase, play a fundamental role in the survival of cancer cells and their resistance to current therapies. The modified nucleotide 6-thio-2’-deoxyguanosine induces telomerase-dependent telomeric DNA modification, DNA damage responses, and selective cancer cell death. Ateganosine-damaged telomeric fragments accumulate in cytosolic micronuclei and activates both innate (cGAS/STING) and adaptive (T-cell) immune responses. The sequential treatment of ateganosine followed by PD-(L)1 inhibitors resulted in profound and persistent tumor regression in advanced, in vivo cancer models by induction of cancer type–specific immune memory. Ateganosine is presently developed as a second or later line of treatment for NSCLC for patients that have progressed beyond the standard-of-care regimen of existing checkpoint inhibitors.

About MAIA Biotechnology, Inc.

MAIA is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Our lead program is ateganosine (THIO), a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. For more information, please visit www.maiabiotech.com.

Forward Looking Statements

MAIA cautions that all statements, other than statements of historical facts contained in this press release, are forward-looking statements. Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause our or our industry’s actual results, levels or activity, performance or achievements to be materially different from those anticipated by such statements. The use of words such as “may,” “might,” “will,” “should,” “could,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “project,” “intend,” “future,” “potential,” or “continue,” and other similar expressions are intended to identify forward looking statements. However, the absence of these words does not mean that statements are not forward-looking. For example, all statements we make regarding (i) the initiation, timing, cost, progress and results of our preclinical and clinical studies and our research and development programs, (ii) our ability to advance product candidates into, and successfully complete, clinical studies, (iii) the timing or likelihood of regulatory filings and approvals, (iv) our ability to develop, manufacture and commercialize our product candidates and to improve the manufacturing process, (v) the rate and degree of market acceptance of our product candidates, (vi) the size and growth potential of the markets for our product candidates and our ability to serve those markets, and (vii) our expectations regarding our ability to obtain and maintain intellectual property protection for our product candidates, are forward looking. All forward-looking statements are based on current estimates, assumptions and expectations by our management that, although we believe to be reasonable, are inherently uncertain. Any forward-looking statement expressing an expectation or belief as to future events is expressed in good faith and believed to be reasonable at the time such forward-looking statement is made. However, these statements are not guarantees of future events and are subject to risks and uncertainties and other factors beyond our control that may cause actual results to differ materially from those expressed in any forward-looking statement. Any forward-looking statement speaks only as of the date on which it was made. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. In this release, unless the context requires otherwise, “MAIA,” “Company,” “we,” “our,” and “us” refers to MAIA Biotechnology, Inc. and its subsidiaries.

Investor Relations Contact
+1 (872) 270-3518
ir@maiabiotech.com

Source: MAIA Biotechnology, Inc.

Released June 24, 2025

QuoteMedia Inc. (QMCI) – Raising Price Target On Favorable Outlook


Tuesday, June 24, 2025

QuoteMedia is a leading software developer and cloud-based syndicator of financial market information and streaming financial data solutions to media, corporations, online brokerages, and financial services companies. The Company licenses interactive stock research tools such as streaming real-time quotes, market research, news, charting, option chains, filings, corporate financials, insider reports, market indices, portfolio management systems, and data feeds. QuoteMedia provides industry leading market data solutions and financial services for companies such as the Nasdaq Stock Exchange, TMX Group (TSX Stock Exchange), Canadian Securities Exchange (CSE), London Stock Exchange Group, FIS, U.S. Bank, Broadridge Financial Systems, JPMorgan Chase, CI Financial, Canaccord Genuity Corp., Hilltop Securities, HD Vest, Stockhouse, Zacks Investment Research, General Electric, Boeing, Bombardier, Telus International, Business Wire, PR Newswire, FolioFN, Regal Securities, ChoiceTrade, Cetera Financial Group, Dynamic Trend, Inc., Qtrade Financial, CNW Group, IA Private Wealth, Ally Invest, Inc., Suncor, Virtual Brokers, Leede Jones Gable, Firstrade Securities, Charles Schwab, First Financial, Cirano, Equisolve, Stock-Trak, Mergent, Cision, Day Trade Dash and others. Quotestream®, QModTM and Quotestream ConnectTM are trademarks of QuoteMedia. For more information, please visit www.quotemedia.com.

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Solid Q1 Results. The company reported solid Q1 results, with revenue growing 3% over the prior year period to $4.8 million, marking the highest quarterly revenue in the company’s history. Adj. EBITDA of $0.4 million in Q1 was moderately lower than our estimate of $0.5 million estimate. We believe its business pipeline appears to be improving and should gain momentum throughout the year and into 2026. 

Capitalizing less development costs. Notably, the company capitalized less development costs in Q1 than in prior quarters, leading to more development costs expensed in Q1. While this impacted Q1, we believe that margins should improve as the company begins to recognize the revenue from the new business “wins” in future quarters. Furthermore, the company will be expensing development costs at a similar rate to Q1 moving forward.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Ocugen (OCGN) – Merger Agreement Moves NeoCart Into A New Company


Tuesday, June 24, 2025

Ocugen, Inc. is a biotechnology company focused on developing and commercializing novel gene therapies, biologicals, and vaccines. The lead product in its gene therapy program, OCU400, is in Phase 1/2 clinical trials for retinitis pigmentosa.

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

NeoCart Transferred To Form New Regenerative Medicine Company. Ocugen has announced that it has entered into a merger agreement with Carisma Therapeutics to form a new company. Ocugen will transfer its wholly-owned regenerative medicine division, OrthoCellix, including NeoCart, an autologous cartilage implant technology that uses a patient’s cells to repair articular cartilage defects in the knee. The all-stock transaction is valued at $150 million, with Ocugen shareholders owning 90% of the new company.

We Expect The New Company To Accelerate NeoCart Development. Ocugen has been refining the Phase 3 trial design and has planned to start Phase 3 trials during FY2025. NeoCart has received Regenerative Medicine Advanced Therapy (RMAT) designation, which accelerates BLA review and could lead to faster approval. While the NeoCart data has been strong, NeoCart was a legacy product that was acquired by Ocugen as part of its 2019 reverse merger with Histogenics. Regenerative medicine is outside Ocugen’s main focus, and we believe it can be developed more rapidly by a company focused on regenerative medicine.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Bitcoin Depot (BTM) – Potential Fuel for Growth


Tuesday, June 24, 2025

Patrick McCann, CFA, Research Analyst, Noble Capital Markets, Inc.

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Shelf registration. On June 20, the company filed a registration statement with the SEC for a $100 million mixed securities shelf registration, which could include Class A common stock, preferred shares, warrants, and units. The registration statement also included an at the money (ATM) sales agreement, which will allow the company to sell up to $50 million in class A common shares directly into the market.

Bolstering capital availability. We view the registration positively, as it provides the company with flexibility to raise capital opportunistically based on market conditions and the strength of BTM’s share price, which is up approximately 230% year-to-date. Importantly, this added capital access could support strategic initiatives such as tuck-in acquisitions or the purchase of additional kiosks, positioning the company to accelerate its network expansion and long-term revenue growth trajectory.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Bit Digital (BTBT) – New Credit Agreement


Tuesday, June 24, 2025

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Credit Agreement. Yesterday, Bit Digital’s WhiteFiber subsidiary announced a CAD$60 million credit facility with Royal Bank of Canada (RBC). We view this step favorably, as the facility not only provides funds to support the continued buildout of WhiteFiber’s Tier-3 AI data center portfolio but also is a confirmation of Bit Digital’s AI business model, in our view.

Terms. While we expect an 8-K to be filed with a full accounting of the terms, the credit agreement is among RBC and ENOVUM Data Centers Corp. and its Montreal II project as borrowers and guarantors, and is non-recourse to WhiteFiber or Bit Digital. It encompasses a real estate term loan, equipment financing, and a revolving facility. The facilities carry interest rates of CORRA plus 250 bps and a 3-year term.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Tesla Stock Soars 9% After Elon Musk Announces Successful Robotaxi Launch in Austin

Key Points:
– Tesla launches its first robotaxi service in Austin with a limited group of early users.
– CEO Elon Musk praised the Tesla AI and chip teams and said rides cost a flat $4.20.
– Despite some operational hiccups, Tesla aims to scale rapidly, challenging Waymo and other rivals.

Tesla’s robotaxi service is currently running on a fleet of Model Y vehicles equipped with its advanced Full Self-Driving (FSD) Unsupervised software. The service is invite-only for now, offered to a community of Tesla enthusiasts, investors, and influencers who frequently promote the company across platforms such as X and YouTube.

Customers participating in the early rollout are charged a flat fare per ride, a detail personally shared by Tesla CEO Elon Musk. In typical fashion, Musk publicly celebrated the milestone, praising the Tesla AI and chip design teams for building the autonomous system from the ground up.

Many early riders reported smooth experiences with the service, some even completing numerous trips without issues. However, concerns remain. Observers have captured footage of the robotaxis performing unexpected maneuvers — including briefly driving against traffic or braking sharply in response to nearby vehicles. Critics argue that these incidents highlight the need for more transparency around safety and system limitations.

Tesla’s autonomous driving system has evolved significantly over the years. The company’s standard Autopilot and premium FSD Supervised features are already available in new EVs, offering capabilities like lane-keeping and automated navigation. However, the fully driverless system powering the robotaxi remains in limited release and is not yet available to the broader public.

The move into robotaxis puts Tesla in direct competition with established players such as Alphabet’s Waymo, which operates a growing fleet of driverless vehicles across multiple U.S. cities. In China, companies like Baidu’s Apollo Go and WeRide are also scaling rapidly, logging millions of autonomous trips annually.

Despite joining the race later than some of its competitors, Tesla brings brand power and a vertically integrated tech stack that could help it catch up quickly. Musk has previously said the company aims to deploy hundreds of thousands — if not over a million — fully autonomous vehicles in the coming years.

The initial rollout has not been without controversy. Some lawmakers and public safety advocates have urged Tesla to delay its robotaxi launch until more rigorous testing and safety data are available. Nonetheless, the company has pushed forward, confident in the capabilities of its proprietary AI systems.

As Tesla expands its service to new cities and gathers feedback from early riders, the robotaxi project is poised to reshape not only how people move but how they think about the future of car ownership, public transit, and automation. Whether Tesla can deliver safe, scalable, and competitive robotaxi experiences remains to be seen — but it’s clear that the road to autonomy has officially begun.

Release – Nicola Mining Inc. Provides $2 Million Line Of Credit To Blue Lagoon Resources, Supporting Strategic Partners And Advancing Gold Production In British Columbia

Research News and Market Data on HUSIF

June 23, 2025

News Releases

VANCOUVER, BC, June 23, 2025 – Nicola Mining Inc. (the “Company” or “Nicola”) (TSX.V: NIM) (OTCQB: HUSIF) (FSE: HLIA) is pleased to announce that it has entered into a credit agreement with Blue Lagoon Resources Inc. (“Blue Lagoon”), providing Blue Lagoon with a $2 million line of credit. This facility is being offered without any security against Blue Lagoon’s mineral property or physical assets, reflecting Nicola’s confidence in Blue Lagoon’s Dome Mountain Gold Project and its near-term production plans.

The credit facility features a competitive interest rate linked to the 3-month SOFR (Secured Overnight Financing Rate), and is repayable over a 12-month term, with interest-only payments required for the first eleven months. Blue Lagoon has the option to extend the loan for an additional 12 months under adjusted terms, providing them with maximum operational flexibility.                                                          

Peter Espig, President and CEO of Nicola Mining, commented:

“We’ve worked closely with the Blue Lagoon team for some time and continue to be impressed by their methodical and disciplined approach. Successfully navigating B.C.’s rigorous permitting process, while also building a strong, trust-based relationship with the Lake Babine Nation, speaks volumes about their leadership. We are pleased to provide this credit facility and look forward to supporting their transition to gold and silver production.”

This credit agreement underscores Nicola’s commitment to supporting its partners and the advancement of responsible mining projects in British Columbia. The structure of the loan allows Blue Lagoon to access capital as needed to support production ramp-up, seize new opportunities, or manage unforeseen short-term needs—all without immediate shareholder dilution.

Should Blue Lagoon choose to draw on this facility, Nicola Mining will maintain a short-term security interest over Blue Lagoon’s gold and silver production from the Dome Mountain Gold Project until the loan is repaid in full.

Nicola remains committed to building strong, mutually beneficial relationships with its partners and stakeholders, and is proud to play a role in supporting the growth of the mining sector in British Columbia.

For additional details, readers are encouraged to review Blue Lagoon Resources’ official news release regarding the credit facility, available here: Blue Lagoon Resources News Release – June 23, 2025.

About Nicola Mining

Nicola Mining Inc. is a junior mining company listed on the TSX-V Exchange and Frankfurt Exchange that maintains a 100% owned mill and tailings facility, located near Merritt, British Columbia. It has signed Mining and Milling Profit Share Agreements with high-grade BC-based gold projects. Nicola’s fully permitted mill can process both gold and silver mill feed via gravity and flotation processes.

The Company owns 100% of the New Craigmont Project, a property that hosts historic high-grade copper mineralization and covers an area of over 10,800 hectares along the southern end of the Guichon Batholith and is adjacent to Highland Valley Copper, Canada’s largest copper mine. The Company also owns 100% of the Treasure Mountain Property, which includes 30 mineral claims and a mineral lease, spanning an area exceeding 2,200 hectares.

For further information, please contact:

Corporate Development
Bill Cawker
+1 (604) 649-0080
info@nicolamining.com 
www.nicolamining.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Oil Prices Fall Despite U.S.-Iran Strikes as Investors Discount Supply Threats

Oil prices tumbled over 3% on Monday despite rising geopolitical tensions in the Middle East, as investors appeared to discount the threat of immediate disruptions to global crude supplies following Iran’s missile strike on a U.S. airbase in Qatar.

U.S. crude futures dropped by $2.32, or 3.14%, to settle at $71.52 per barrel, while global benchmark Brent crude declined by $2.41, or 3.13%, to $74.60. The sell-off marked a sharp reversal from gains seen Sunday evening, when Brent briefly surged above $81 following news of U.S. airstrikes on Iranian nuclear facilities.

Iran’s Revolutionary Guard confirmed it had launched missiles at Al-Udeid Air Base in Qatar, home to U.S. and coalition forces. While no casualties or infrastructure damage were reported, the strike underscored the escalating tit-for-tat between Tehran and Washington.

Despite the headline risk, oil markets remained notably calm. “The market is pricing in a de-escalation path,” said Jorge Leon, head of geopolitical risk at Rystad Energy. “But the potential for things to unravel very quickly still exists.”

President Donald Trump, meanwhile, took to social media to urge for lower oil prices, telling “everyone” — likely including domestic producers — to help keep prices in check. The president’s comments reflect his administration’s concern over inflation ahead of the November election.

Geopolitical Flashpoint: Strait of Hormuz

The key long-term risk remains Iran’s threat to close the Strait of Hormuz, through which nearly 20% of the world’s oil passes daily. Iranian state media reported that parliament supported shutting down the vital waterway, although the final decision lies with Iran’s national security council.

U.S. Secretary of State Marco Rubio warned that such a move would be “economic suicide” for Iran, noting that the Islamic Republic relies on the strait for its own oil exports. “We retain options to deal with that,” Rubio said, hinting at potential multilateral military responses.

Rubio also urged China, Iran’s top oil customer, to use its influence to dissuade Tehran from taking further steps that could disrupt regional stability. “About half of China’s seaborne oil comes through that corridor,” he said.

Market Psychology: Risk vs. Supply

Despite the barrage of developments, investors seem confident that major disruptions to supply remain unlikely in the short term. Iran continues to export nearly 1.84 million barrels per day, largely to China, and major production hubs remain operational.

Memories of 2019 — when Iranian-linked groups targeted Saudi oil facilities — and the subsequent quick recovery, may also be tempering investor anxiety. Additionally, diplomatic overtures between Iran and Saudi Arabia are viewed as a stabilizing factor in an otherwise volatile region.

The International Energy Agency (IEA) said it is closely monitoring the situation and is prepared to release strategic reserves if necessary. The IEA currently holds 1.2 billion barrels in emergency stockpiles.

For now, oil prices may remain rangebound as investors weigh the potential for further escalation against the apparent reluctance from both sides to push the conflict to extremes.

Release – GDEV Announces Change in Leadership

Research News and Market Data on GDEV

LIMASSOL, Cyprus, June 23, 2025 – GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”), today announced that Olga Loskutova will depart from her role as Chief Operating Officer effective July 1, 2025.

Since assuming the COO position in October 2024, Ms. Loskutova has successfully established the planning, reporting and cross-studio coordination frameworks that underpin GDEV’s operating model. 

“Olga’s operational expertise helped us put the right structure in place at a critical moment,” said Andrey Fadeev, Founder and Chief Executive Officer of GDEV. “We are grateful for her contribution and wish her continued success in her next chapter.”

ABOUT GDEV

GDEV is a gaming and entertainment holding company, focused on development and growth of its franchise portfolio across various genres and platforms. With a diverse range of subsidiaries including Nexters and Cubic Games, among others, GDEV strives to create games that will inspire and engage millions of players for years to come. Its franchises, such as Hero Wars, Island Hoppers, Pixel Gun 3D and others have accumulated over 550 million installs and $2.5 billion of bookings worldwide. For more information, please visit www.gdev.inc 

CONTACTS

Investor Relations

Roman Safiyulin | Chief Corporate Development Officer

investor@gdev.inc

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Certain statements in this press release may constitute “forward-looking statements” for purposes of the federal securities laws. Such statements are based on current expectations that are subject to risks and uncertainties. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. 

The forward-looking statements contained in this press release are based on the Company’s current expectations and beliefs concerning future developments and their potential effects on the Company. There can be no assurance that future developments affecting the Company will be those that the Company has anticipated. Forward-looking statements involve a number of risks, uncertainties (some of which are beyond the Company’s control) or other assumptions. You should carefully consider the risks and uncertainties described in the “Risk Factors” section of the Company’s 2024 Annual Report on Form 20-F, filed by the Company on March 31, 2025, and other documents filed by the Company from time to time with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should any of the Company’s assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Release – SKYX Announces U.S. and Global Demand Surge Towards the Launch of Its New Disruptive Patented All-In-One Smart Turbo Heater & Ceiling Fan

Research News and Market Data on SKYX

Company Anticipates Q3 Winter Launch Will Support its Path to Cash-Flow Positive in 2025

Ceiling Fan and Space Heater Category Represents a Multi-Billion-Dollar Annual Market with Tens of Millions of Units Sold in the U.S. Alone

Due to Strong Demand, SKYX Will Launch Two Different Models (see images below) of Its Disruptive All-In-One Smart Turbo Heater & Fan; Manufacturing Has Commenced Through SKYX’s Long-Term Manufacturing Partners

MIAMI, June 23, 2025 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (“SKYX” or the “Company”), a highly disruptive smart home platform technology company with over 97 issued and pending patents globally and a growing portfolio of over 60 lighting and home décor websites, with a mission to make homes and buildings become smart, safe, and advanced as the new standard, today announced strong U.S. and international demand for its newly patented all-in-one smart ceiling fan and heater (see images below).

This highly innovative product-integrating a ceiling fan with a built-in heater-is designed to address a massive market opportunity for all four seasons. The combined ceiling fan and portable heater category is a multi-billion-dollar market, with tens of millions of units sold annually in the U.S. alone.

In response to the strong demand, SKYX will introduce two different versions of the product each in 6 to 8 colors, designed to meet both residential and commercial needs. Production has officially begun with the Company’s manufacturing partners, and SKYX anticipates a broad launch in Q3 2025, aligned with the upcoming winter season.

The Company believes that the successful launch of this product line is a critical milestone on its path toward achieving cash-flow positive operations in 2025.

Rani Kohen, Founder and Executive Chairman of SKYX Platforms Corp., stated:
“We are experiencing unprecedented interest in our all-in-one smart heater and ceiling fans from both U.S. and global markets. This product exemplifies our commitment to innovation, safety, and global market products. As we prepare for our upcoming launch, we believe this breakthrough solution will drive significant value for our customers, partners, and shareholders.”

To view SKYX’s technologies in action, click here: CLICK HERE

About SKYX Platforms Corp.

As electricity is a standard in every home and building, our mission is to make homes and buildings become safe-advanced and smart as the new standard. SKYX has a series of highly disruptive advanced-safe-smart platform technologies, with over 97 U.S. and global patents and patent pending applications. Additionally, the Company owns over 60 lighting and home decor websites for both retail and commercial segments. Our technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings. We believe that our products are a necessity in every room in both homes and other buildings in the U.S. and globally. For more information, please visit our website at https://skyplug.com/ or follow us on LinkedIn.

Forward-Looking Statements

Certain statements made in this press release are not based on historical facts, but are forward-looking statements. These statements can be identified by the use of forward-looking terminology such as “aim,” “anticipate,” “believe,” “can,” “could,” “continue,” “estimate,” “expect,” “evaluate,” “forecast,” “guidance,” “intend,” “likely,” “may,” “might,” “objective,” “ongoing,” “outlook,” “plan,” “potential,” “predict,” “probable,” “project,” “seek,” “should,” “target” “view,” “will,” or “would,” or the negative thereof or other variations thereon or comparable terminology, although not all forward-looking statements contain these words. These statements reflect the Company’s reasonable judgment with respect to future events and are subject to risks, uncertainties and other factors, many of which have outcomes difficult to predict and may be outside our control, that could cause actual results or outcomes to differ materially from those in the forward-looking statements. Such risks and uncertainties include statements relating to the Company’s ability to successfully launch, commercialize, develop additional features and achieve market acceptance of its products and technologies and integrate its products and technologies with third-party platforms or technologies; the Company’s efforts and ability to drive the adoption of its products and technologies as a standard feature, including their use in homes, hotels, offices and cruise ships; the Company’s ability to capture market share; the Company’s estimates of its potential addressable market and demand for its products and technologies; the Company’s ability to raise additional capital to support its operations as needed, which may not be available on acceptable terms or at all; the Company’s ability to continue as a going concern; the Company’s ability to execute on any sales and licensing or other strategic opportunities; the possibility that any of the Company’s products will become National Electrical Code (NEC)-code or otherwise code mandatory in any jurisdiction, or that any of the Company’s current or future products or technologies will be adopted by any state, country, or municipality, within any specific timeframe or at all; risks arising from mergers, acquisitions, joint ventures and other collaborations; the Company’s ability to attract and retain key executives and qualified personnel; guidance provided by management, which may differ from the Company’s actual operating results; the potential impact of unstable market and economic conditions on the Company’s business, financial condition, and stock price; and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission, including its periodic reports on Form 10-K and Form 10-Q. There can be no assurance as to any of the foregoing matters. Any forward-looking statement speaks only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by U.S. federal securities laws.

Investor Relations Contact:
Jeff Ramson
PCG Advisory
jramson@pcgadvisory.com

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/3b2fd9fa-554e-49cc-8d42-e1d8c21f20d8https://www.globenewswire.com/NewsRoom/AttachmentNg/593f4ca0-0079-427f-ab81-4562ae4e2fd4

Release – Xcel Brands Announces Strategic Partnership with Global Fashion Icon Coco Rocha

Research News and Market Data on XELB

PDF Version

June 23, 2025 at 8:00 AM EDT

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) — Xcel Brands (NASDAQ: XELB), an industry leading media and consumer products company specializing in building influencer-driven brands through social commerce and livestreaming, is proud to announce a groundbreaking new partnership with supermodel, advocate, and founder of Coco Rocha Model Camp, Coco Rocha.

With more than two decades at the highest level of the fashion industry—having graced over 100 magazine covers, been shot by top photographers across the globe, and walked runways for luxury fashion houses ranging from Chanel, Louis Vuitton, John Galliano, Prada and Schiaparelli to Jean Paul Gaultier, Tom Ford, Moschino, and Marc Jacobs—Coco Rocha brings a rare depth of experience and insight to this collaboration. Rocha’s illustrious career has granted her a front-row seat to the inner workings of the world’s most legendary designers. Together, Coco Rocha and Xcel Brands will develop a bold, thoughtfully crafted fashion brand designed for women who lead with both strength and style.

“What excites me about partnering with Xcel is the opportunity to finally channel all of those unbelievable lived experiences into something of my own,” said Rocha. “This isn’t about chasing trends or putting my name on a label—it’s about designing elevated essentials that reflect the life I live now as a mother, businesswoman, and creative.”

This collaboration aims to speak to women seeking pieces that feel as powerful and dynamic as their daily lives. Coco Rocha’s collection will deliver runway-inspired elegance with everyday practicality.

Robert W. D’Loren, Chairman and CEO of Xcel Brands, said, “Coco Rocha is one of the most influential fashion figures of our time. Her perspective, creativity, and commitment to authenticity make her the perfect partner for our next brand launch. We are thrilled to work alongside her in building something empowering and extraordinary.”

This announcement further pushes Xcel’s commitment to redefining modern fashion through innovative partnerships with authentic, visionary creators. For more information, visit www.xcelbrands.com  

About Xcel Brands
Xcel Brands, Inc. (NASDAQ: XELB) is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Xcel was founded in 2011 with a vision to reimagine shopping, entertainment, and social media as social commerce. Xcel owns the Halston, Judith Ripka, and C. Wonder brands, as well as the co-branded collaboration brands TowerHill by Christie Brinkley, LB70 by Lloyd Boston, Trust. Respect. Love. by Cesar Millan, and GemmaMade by Gemma Stafford, and also holds noncontrolling interests or long-term license agreements in the Isaac Mizrahi brand, Orme Live and Jenny Martinez Live brands. Xcel also owns and manages the Longaberger brand through its controlling interest in Longaberger Licensing, LLC. Xcel is pioneering a true modern consumer products sales strategy which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, brick-and-mortar retailers, and e-commerce channels to be everywhere its customers shop. The company’s brands have generated in excess of $5 billion in retail sales via livestreaming in interactive television and digital channels alone and consisting of over 20,000 hours of content production time in live-stream and social commerce. The brand portfolio reaches in excess of 40 million social media followers with broadcast reach into 200 million households. Headquartered in New York City, Xcel Brands is led by an executive team with significant live streaming, production, merchandising, design, marketing, retailing, and licensing experience, and a proven track record of success in elevating branded consumer products companies. For more information, visit www.xcelbrands.com.

About Coco Rocha  
Coco Rocha is an internationally acclaimed supermodel, entrepreneur, and educator who has redefined the role of a model through two decades of innovation and influence. Named Model of the Year by Elle and Marie Claire, and hailed by Vogue Paris and Vogue Italia as one of the top models of all time, she has graced the runways of every major fashion house and appeared in countless international campaigns and covers.

Widely known as the “Queen of Pose”, Coco is considered one of the most technically proficient and versatile models of her generation. In 2014, she authored Study of Pose, a 2,000-page visual encyclopedia that has become a go-to reference for models and photographers alike. A pioneer in digital influence, Coco was the first high-fashion model to fully embrace social media—amassing millions of followers and earning recognition from Time magazine and TikTok as a leading voice in fashion.

An outspoken advocate for model rights, she played a pivotal role in passing legislation in New York to protect underage models. In 2018, she launched the Coco Rocha Model Camp (CRMC), a first-of-its-kind program offering hands-on modeling training combined with career and business strategy. Nearly 5,000 students have trained under Coco—including Kendall Jenner, Alix Earle, Bryce Dallas Howard, Dixie D’Amelio, Tabria Majors, and more.

She has shared her expertise through guest lectures at Harvard, Brown, and SCAD, and co-founded Nomad MGMT, a boutique modeling agency with offices in three countries. Beyond fashion, Coco is an active investor and advisor to early-stage startups in tech, media, and commerce. She lives in New York with her husband and creative partner, James Conran, and their three children.

Coco Rocha is represented by The Lions Management.

For further information, please contact:
Seth Burroughs
Xcel Brands
sburroughs@xcelbrands.com

For press inquiries with Coco Rocha, please contact:
Bianca Bianconi
Bianca.Bianconi@42West.com
Devin Wolf
Devin.Wolf@42West.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d9ea093c-b36d-40db-a59d-54596ed22710

Primary Logo
Coco Rocha

 

Coco Rocha

Source: Xcel Brands, Inc

Release – Lucky Strike Entertainment Appoints Industry Leaders Richard Born and Jason Harinstein to Board of Directors

Research News and Market Data on LUCK

06/23/2025

RICHMOND, Va.–(BUSINESS WIRE)– Lucky Strike Entertainment (NYSE: LUCK), one of the world’s premier Owner/ Operators of location-based entertainment, announced today the appointment of two esteemed executives to its Board of Directors: Richard Born, a pioneering force in hospitality-focused real estate, and Jason Harinstein, a recognized leader in finance, technology, and business strategy. Their appointments are effective June 23, 2025.

These strategic additions bring a wealth of expertise in hospitality, real estate, finance, and technology to Lucky Strike’s board, reinforcing the company’s commitment to innovation, growth, and world-class guest experiences. Mr. Born will serve on the Nominating and Corporate Governance Committee of the Board, and Mr. Harinstein will join the Board’s Audit and Compensation Committees.

Mr. Born is widely regarded as one of the most influential developers in New York’s boutique hotel landscape. As co-founder of BD Hotels, he has spent over 35 years transforming properties into cultural and hospitality landmarks. His portfolio includes interests in more than 25 hotels and 20 additional real estate holdings, and he remains actively involved in the management and operations of over half of these assets. His projects include iconic properties such as the Hotel Chelsea, the Bowery Hotel, the Mercer, and the Ludlow, which have redefined the guest experience and helped shape the hospitality scene in New York as well as other major markets. Mr. Born holds a medical doctorate from the New York University School of Medicine.

Mr. Harinstein brings over two decades of executive leadership from some of the industry’s most innovative and data-driven companies. He currently serves as Chief Financial Officer of Collectors Holdings Inc., a premier platform for authentication and digital marketplaces. Prior to that, he was the Chief Financial Officer of Flatiron Health, a healthcare technology company, and held senior roles at Google and Groupon, where he helped drive corporate strategy, and business development during key phases of expansion. Mr. Harinstein is also a member of the board of directors of Groupon and Funko. He holds a master’s of business administration from the University of Chicago Booth School of Business.

“Richard and Jason are best-in-class leaders in their respective fields—each bringing a unique blend of operational insight, visionary thinking, and financial discipline,” said Thomas Shannon, Founder, Chairman, and CEO of Lucky Strike Entertainment. “Their addition to our board reflects our commitment to assembling world-class talent to guide our continued growth, innovation, and long-term vision.”

The appointments underscore Lucky Strike’s continued investment in top-tier leadership as the company continues to expand its footprint and deepen its position as an industry leader.

About Lucky Strike Entertainment

Lucky Strike Entertainment is one of the world’s premier location-based entertainment platforms. With over 360 locations across North America, Lucky Strike Entertainment provides experiential offerings in bowling, amusements, water parks, and family entertainment centers. The company also owns the Professional Bowlers Association, the major league of bowling and a growing media property that boasts millions of fans around the globe. For more information on Lucky Strike Entertainment, please visit IR.LuckyStrikeEnt.com.

For Media:
IR@LSEnt.com

Source: Lucky Strike Entertainment Corporation